Skip to main content

Mirum Pharmaceuticals, Inc.

MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001759425

In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 10 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Mirum Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
146
+29 vs. Q1 2023
Shares held
36.9M
+2.27M (+6.5%) vs. Q1 2023
Total value
$955.6M
+$122.8M (+14.7%) vs. Q1 2023
New holders
38
58 more added
Sold out
9
28 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MIRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 146 institutions
Q1 2021: 61 institutionsQ2 2021: 67 institutionsQ3 2021: 73 institutionsQ4 2021: 86 institutionsQ1 2022: 99 institutionsQ2 2022: 110 institutionsQ3 2022: 112 institutionsQ4 2022: 104 institutionsQ1 2023: 117 institutionsQ2 2023: 146 institutionsQ3 2023: 159 institutionsQ4 2023: 187 institutionsQ1 2024: 172 institutionsQ2 2024: 161 institutionsQ3 2024: 178 institutionsQ4 2024: 205 institutionsQ1 2025: 214 institutionsQ2 2025: 214 institutionsQ3 2025: 272 institutionsQ4 2025: 284 institutionsQ1 2026: 311 institutionsQ2 2026: 326 institutions
Value heldQ2 2023: $955.6M
Q1 2021: $463.3MQ2 2021: $404.6MQ3 2021: $465.0MQ4 2021: $395.7MQ1 2022: $590.4MQ2 2022: $569.4MQ3 2022: $709.1MQ4 2022: $650.2MQ1 2023: $832.9MQ2 2023: $955.6MQ3 2023: $1.55BQ4 2023: $1.48BQ1 2024: $1.34BQ2 2024: $1.83BQ3 2024: $2.08BQ4 2024: $2.19BQ1 2025: $2.44BQ2 2025: $2.82BQ3 2025: $4.20BQ4 2025: $4.82BQ1 2026: $6.29BQ2 2026: $8.36B
Institutions holding MIRM and their total value by quarter
QuarterHoldersValue
Q2 2026326$8.36B
Q1 2026311$6.29B
Q4 2025284$4.82B
Q3 2025272$4.20B
Q2 2025214$2.82B
Q1 2025214$2.44B
Q4 2024205$2.19B
Q3 2024178$2.08B
Q2 2024161$1.83B
Q1 2024172$1.34B
Q4 2023187$1.48B
Q3 2023159$1.55B
Q2 2023146$955.6M
Q1 2023117$832.9M
Q4 2022104$650.2M
Q3 2022112$709.1M
Q2 2022110$569.4M
Q1 202299$590.4M
Q4 202186$395.7M
Q3 202173$465.0M
Q2 202167$404.6M
Q1 202161$463.3M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Mirum Pharmaceuticals, Inc.; share changes are against Q1 2023.

Institutions holding MIRM in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Charles Schwab Investment Management Inc72,284$1.87M0.00%+19,545+37.1%Added
Nuveen Asset Management, LLC75,600$1.96M0.00%+3,906+5.4%Added
Bank of America Corp84,735$2.19M0.00%−21,128−20.0%Reduced
Price T Rowe Associates Inc99,681$2.58M0.00%+87,753+735.7%Added
Two Sigma Investments, LP103,110$2.67M0.01%+103,110New
Morgan Stanley104,479$2.70M0.00%+60,285+136.4%Added
Silverarc Capital Management, LLC106,375$2.75M0.93%+436+0.4%Added
UBS Group AG110,646$2.86M0.00%+70,080+172.8%Added
Deutsche Bank AG111,411$2.88M0.00%+48,020+75.8%Added
Bank of New York Mellon Corp112,190$2.90M0.00%+52,333+87.4%Added
Rafferty Asset Management, LLC115,893$3.00M0.02%+29,732+34.5%Added
Highlander Partners, L.P.122,980$3.18M3.58%00.0%Unchanged
Soleus Capital Management, L.P.176,000$4.55M0.51%−66,000−27.3%Reduced
New York State Common Retirement Fund209,252$5.41M0.01%+197,154+1,629.6%Added
Ensign Peak Advisors, Inc225,700$5.84M0.01%00.0%Unchanged
Wasatch Advisors Inc230,461$5.96M0.04%+230,461New
Silvercrest Asset Management Group LLC234,268$6.06M0.04%+32,888+16.3%Added
Penn Capital Management Co Inc239,274$6.19M0.60%+239,274New
Jane Street Group, LLC247,674$6.41M0.01%+202,379+446.8%Added
Janus Henderson Group PLC265,612$6.86M0.00%+224,328+543.4%Added
Northern Trust Corp273,859$7.08M0.00%+59,662+27.9%Added
Goldman Sachs Group Inc274,896$7.11M0.00%−117,476−29.9%Reduced
Barclays PLC287,150$7.43M0.00%−12,313−4.1%Reduced
Woodline Partners LP327,818$8.48M0.10%−196,062−37.4%Reduced
William Blair Investment Management, LLC337,414$8.73M0.03%+337,414New
Geode Capital Management, LLC525,562$13.6M0.00%+107,348+25.7%Added
Point72 Asset Management, L.P.601,038$15.5M0.05%+43,600+7.8%Added
Perceptive Advisors LLC601,566$15.6M0.45%00.0%Unchanged
Franklin Resources Inc611,081$15.8M0.01%+210,579+52.6%Added
AXA S.A.668,875$17.3M0.06%−219,679−24.7%Reduced
Prosight Management, LP675,000$17.5M5.11%+107,174+18.9%Added
Pictet Asset Management SA883,979$22.9M0.03%+79,850+9.9%Added
Nicholas Investment Partners, LP915,119$23.7M1.62%+915,119New
Polar Capital Holdings Plc925,000$23.9M0.16%−4,907−0.5%Reduced
Tang Capital Management LLC1,137,107$29.4M4.33%−32,893−2.8%Reduced
Cadian Capital Management, LP1,264,922$32.7M1.55%+530,000+72.1%Added
Citadel Advisors LLC1,429,845$37.0M0.04%+60,500+4.4%Added
State Street Corp1,494,417$38.7M0.00%+323,992+27.7%Added
Vanguard Group Inc1,594,658$41.3M0.00%+320,831+25.2%Added
RiverVest Venture Management LLC1,621,118$41.9M46.52%00.0%Unchanged
Novo Holdings A/S1,684,193$43.6M3.37%00.0%Unchanged
Rock Springs Capital Management LP1,820,733$47.1M1.12%+25,000+1.4%Added
BlackRock Inc.2,030,375$52.5M0.00%+320,549+18.7%Added
NEA Management Company, LLC2,186,243$56.6M4.32%−2,000,000−47.8%Reduced
Eventide Asset Management, LLC3,459,201$89.5M1.51%+1,400,000+68.0%Added
Frazier Life Sciences Management, L.P.4,360,107$112.8M6.74%+500,000+13.0%Added
Deerfield Management Company, L.P. (Series C)0$00.00%−2,032,335−100.0%Sold out
Wellington Management Group LLP0$00.00%−154,750−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−109,336−100.0%Sold out
Repertoire Partners LP0$00.00%−49,900−100.0%Sold out
Millennium Management LLC0$00.00%−15,363−100.0%Sold out
Ergoteles LLC0$00.00%−12,012−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−10,250−100.0%Sold out
Values First Advisors, Inc.0$00.00%−8,497−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−2,800−100.0%Sold out